New Indications for Ultrasound in the Staging of Cervical Cancer
Not Applicable
Withdrawn
- Conditions
- Cervical Cancer
- Registration Number
- NCT00451945
- Lead Sponsor
- Rigshospitalet, Denmark
- Brief Summary
The purpose is to investigate and evaluate two new diagnostic methods using ultrasound in the staging of cervical cancer.
1. 3-D-ultrasound of the tumour to estimate its volume and local spread
2. Fusion of PET/CT and ultrasound to evaluate and biopsy lymph nodes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
- Cervical cancer,
- PET/CT pos. lymph nodes,
- Patients over 18 years old
Exclusion Criteria
- Pregnancy,
- Lactating,
- Diabetic
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does 3-D-ultrasound utilize to assess tumour volume in cervical cancer staging?
How does the fusion of PET/CT and ultrasound improve lymph node evaluation compared to standard imaging techniques in cervical cancer?
Which biomarkers are associated with local tumour spread in cervical cancer for ultrasound-based staging methods?
What are the potential adverse events of using ultrasound for cervical cancer staging and how are they managed?
Are there any combination therapies or competitor drugs that enhance ultrasound staging accuracy in cervical cancer?
Trial Locations
- Locations (1)
Copenhagen univercity hospital, Department of Radiology, section of ultrasound
🇩🇰Copenhagen, Denmark
Copenhagen univercity hospital, Department of Radiology, section of ultrasound🇩🇰Copenhagen, Denmark